The 2012 French Infectious Disease Testing Market

Date: March 28, 2012
Pages: 980
Price:
US$ 5,900.00 US$ 5,015.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: FABB0FDFBA2EN
Leaflet:

Download PDF Leaflet

The 2012 French Infectious Disease Testing Market
This report presents a comprehensive analysis of the French infectious disease testing market, including:
  • Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in French hospitals, blood banks and commercial laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 980 pages and 160 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. AIDS
    a. Background
  • Structure and Composition
  • Classification
  • Origin of AIDS
  • Animal Lentivirus Systems
  • Virus Receptos
  • HIV Infections in Humans
    • Pathogenesis & Pathology: Overview of HIV Infection Course
  • CD4T Lymphocytes and Memory Cells
  • Monocytes and Macrophages
  • Lymphoid Organs
  • Neural Cells
  • Viral Coinfections
    • Clinical Findings
  • Plasma Viral Load
  • Pediatric AIDS
    • Neurologic Disease
    • Opportunistic Infections
    • Cancer
  • Immunity
    • Virus Isolation
    • Serology
    • Detection of Viral Nucleic Acid and Antigens
  • Infectivity
  • Epidemiology
    • Worldwide Spread of AIDS
    • United States
    • Routes of Transmission
    b. Diagnostic Tests
  • Laboratory Diagnosis
    • Enzyme Immunoassay Interpretation
    • Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays
  • Competition Assays
  • Western Blot Technique
  • Immuno-Fluorescence Assay (IFA)
  • Radioimmunoprecipitation
  • HIV-1/HIV-2 Combination Testing
  • Methods of HIV-Antigen Detection
  • Antigen Assays and Blood Screening
  • Urine Tests
  • Immunopathogenic Mechanism of HIV Infection
  • DNA Probes
    • Overview
    • Quantitative Polymerase Chain Reaction
    • In Situ PCR
    • Needed Improvements
  • Viral Load/Drug Resistance Testing
  • Genotype and Phenotype Testing
  • Blood Banking Consideration
    c. Vaccines and Drugs
    • Antiviral Drugs
    • Vaccines Against HIV
  • Transmission of HIV in Blood Products
  • HIV Transmission in Transplant and Artificial Insemination Recipients
  2. Adenovirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    d. Adeno-Associated Viruses(AAV)
    3. Aeromonas
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    4. Anthrax/Bacillus Anthracis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    5. Arboviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    6. Babesiosis
    a. Background
  7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  8. Blastocystis Hominis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  9. Brucella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  10. Campylobacter
    a. Background
    b. Diagnostic Tests
  • Identification from Culture
    c. Vaccines and Drugs
  11. Candida
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  12. Chagas Disease
    a. Background
  13. Chancroid
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  14. Chlamydia
    a. Background
  • Chlamydia Psittaci
  • Chlamydia Pneumoniae
  • Chlamydia Trachomatis
    b. Diagnostic Tests
    c. Vaccines and Drugs
  15. Clostridium Difficile
    a. Background
  • Pediatric Infections
  • Epidemiology
    b. Diagnostic Tests
  • Counterimmunoelectrophoresis
  • Fluorescent-Antibody Assays
  • Poloymerase Chain Reactions
    c. Drugs and Vaccines
  16. Coronaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  17. Coxsackieviruses
    a. Background
  • Herpangina
  • Hand-foot-and-mouth syndrome
  • Hepidemic Conjuctivitis
  • Pharingitis
  • Epidemic Pleurodynia
  • Myodarditis,Pericarditis
  • Overwhelming Infection of the Newborn
  • Acute Aseptic Meningitis
  • Undifferentiated Febrile Illness
  • Fever with upper respiratory infection
  • Encephalitis
  • Asymptomatic Infection
    b. Diagnostic Tests
    c. Vaccines and Drugs
  18. Creutzfeldt-Jakob’s Disease
    a. Background
  • Blood Transmission
    b. Diagnostic Tests
  • Major Commercial and Academic Players
    • Bayer
    • Disease Sciences/Bio Tec Global
    • Imperial College of Medicine
    • Ortho-Clinical Diagnostics
    • Pall
    • ProMetic Life Sciences
    • Proteome Sciences/Idexx
    • Q-One Biotech
    • Serono
    • U.S. Agricultural Research Service
    c. Vaccines
  19. Cryptosporidium Parvum
    a. Background
    b. Diagnostic Tests
  • Histologic
  • Laboratory Parasitology
  • Serodiagnosis
    c. Vaccines and Drugs
  20. Cyclospora Cayetanensis
    a. Background
  • Asymptomatic Infection
  • Diarrhea in Immunocompetent Persons
  • Diarrhea in Immunocompromisedersons
    b. Diagnostic Tests
    c. Vaccines and Drugs
  21. Cytomegalovirus
    a. Background
  • Chorioretinitis
  • Gastrointestinal
  • Central Nervous System Disease
    b. Diagnostic Tests
    c. Vaccines and Drugs
  22. Ebola Virus
    a. Background
  • Epidemiology
  • Hemorrhagic Fever
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2  3. E. Coli
    a. Background
  • Role of Escherichia Coli in Causing Diarrhea
  • EPEC
  • ETEC
  • EIEC
  • EHEC
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2  4. EchoVirus
    a. Background
  • Acute Aseptic Miningitisis
  • Encephalitis
  • Exanthems
  • Respiratory Disease
  • Myope;ricarditis
  • Neonatal Infections
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2  5. Encephalitis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2  6. Enteroviruses
    a. Background
    b. Diagnostic Tests
  • Viral Isolation and Identification
  • Antibody Tests
    c. Vaccines and Drugs
  27. Epstein-Barr Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  28. Giardia Lamblia
    a. Background
  • Life Cycle and Morphology
  • Morphology of Trophozoites
  • Clinical Disease
    b. Diagnostic Tests
    c. Vaccines and Drugs
  29. Gonorrhea
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  30. Granuloma Inguinale
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  31. Hantavirus
    a. Background
  • Identification of the Agent
  • Transmission
  • Other Rodent Hantaviruses
  • Distribution
  • Hantavirus Diseases
  • Epidemiology
  • Addendum in Proof-Northeastern Connection
  • Previously Unknown Pathogens
  • Cases Nationwide
    b. Diagnostic Tests
  • An Immunohistochemistry Approach
  • Hantavirus Rapid Diagnostic Test
  • ELISA Diagnosis of Hantavirus Pulmonary Syndrome
  • IgG ELISA
  • IgM Capture ELISA
    c. Vaccines and Drugs
  32. Helicobacter Pylori
    a. Background
  • Pathogenesis
  • Role in Peptic Ulcer Disease
  • Role in Gastric Cancer
  • Nonulcer Dyspepsia
    b. Diagnostic Tests
    c. Vaccines and Drugs
  • Specific Therapeutic Regimens
  • Who Should Be Treated?
  • Participants in Controlled Clinical Trials
  • Patients with Refractory Peptic Ulcer
  • Patients with Refractory NUD
  • Patients in High-Risk Groups for Gastric Cancer
  33. Hepatitis
    a. Background
    b. Hepatitis A
    c. Hepatitis B
    d. Hepatitis C
  • Classification
  • Transmission of Infection
  • Occupational Hazards
  • Acute Hepatitis
  • Diagnosis of Acute Infection
  • Chronic Hepatitis
  • HCV and Other Chronic Liver Diseases
  • Alcoholic Liver Disease
  • Hepatitis B Coinfection
  • Cirrhosis and Hepatocellular Carcinoma
  • Diagnostic Tests
  • Possible Indications for HCV RNA Testing
  • Conclusions and Future Direction
    e. Hepatitis D
  • Historical Perspective
  • Epidemiology
  • HBV-HDV 'Coinfection' vs. 'Superinfection'
  • Methods of Detecting HDV
  • Prevention
    f. Hepatitis E
  • Background
  • Prevalence of the Disease
  • Diagnostic Tests
  • Epidemiologic Serosurveys
  • Serologic Cross-Reactivity
    g. Hepatitis G
  • Vaccines and Drugs
  34. Herpes Simplex Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  35. Human Herpes Virus-6 (HHV-6)
    a. Background
  • HIV-6 Infections
    b. Diagnostic Tests
    c. Vaccines and Drugs
  36. Influenza Viruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  37. Legionella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  38. Lyme Disease
    a. Background
  • Clinical Description
  • Clinical Case Definition
  • Laboratory Criteria for Diagnosis
  • Case Classification
    b. Diagnostic Tests
    c. Vaccines and Drugs
  39. Lymphogranuloma Venereum (LGV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  40. Malaria
    a. Background
    b. Diagnostic Tests
  • Potential Diagnositic Problems with Positive Patients from Non-endemic Areas
    • Patient
    • Laboratory
    • Physician
    c. Vaccines and Drugs
  41. Measles (Rubeola)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  42. Meningitis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  • Development of Polysaccharide Vaccines
  • Quadrivalent Vaccine Development
  • Meningococcal A.C.Y. & W-135 Vaccines
  • Efficacy of Group C Vaccine
  • Efficacy of Group A Vaccine
  • Combinations of Group A and C Vaccines
  • Group B Efficacy Trials
  • Future Direction
  43. Microsporidium
    a. Background
  • Prevalence and Geographic Distribution
  • Sources of Human Infection and Transmission
    b. Diagnostic Tests
  • Light Microscopic Examination of Stool Specimens By Chromotrope Staining
  • Stool Concentration Methods
  • Chemofluorescent Agents
  • Giemsa Staining of Stool Specimens
  • Cytologic Diagnosis
  • Histologic Examination
  • Electron Microscopy
  • Examination of Bodily Fluids
  • Examination of Tissue Sections
  • Immunofluorescence Detection Procedures
  • Serology
  • Cell Culture
  • Approach to Diagnosis
  • Evaluation of Patients with Presumptive Intestinal Microsporidiosis
  • Evaluation of Patients with Presumptive Ocular Microsporidiosis
    c. Vaccines and Drugs
  44. Mononucleosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  45. Mumps
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  • Efficacy of Vaccination
  • Future Issues
  46. Mycoplasma
    a. Background
  • Ureaplasma Urealyticum & Mycoplasma Hominis
    b. Diagnostic Tests
    c. Vaccines and Drugs
  47. Papillomaviruses
    a. Background
  • HPV in Cancer
  • Cervical Neoplasm
    b. Diagnostic Tests
    c. Vaccines and Drugs
  • Prevention
  48. Parvovirus B19
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  49. Pneumonia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  50. Polyomaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  51. Pseudomonas Aeruginosa
    a. Background
  • Virulence Factors
    b. Diagnostic Tests
    c. Vaccines and Drugs
  52. Rabies
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  53. Respiratory Syncytial Virus (RSV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  54. RhinoViruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  55. RotaVirus (REOVIRUS)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5  6. Rubella(MEASLES)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  • Developing Countries
  • Elimination and Eradication of Measles
  • New Developments
  57. Salmonellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  58. Septicemia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  59. Shigellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  60. Staphylococcus Aureus
    a. Background
  • The Genus Taphylococcus
    b. Diagnostic Tests
    c. Vaccines and Drugs
  • Prevention
  61. Streptococci
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  • Group A Streptococci
  • Group B Streptococci
  62. Syphilis
    a. Background
    b. Diagnostic Tests
  • Biopsy
  • Rabbit Infectivity Testing
  • Other Diagnostic Modalities
    c. Vaccines and Drugs
  • Syphilis and HIV Infection
  • Syphilis As a Cofactor for HIV Transmission
  • Basic Science Issues
  63. Toxoplasmosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  64. Trichomonas Vaginalis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  65. Tuberculosis
    a. Background
    b. Diagnostic Tests
  • Microscopic Characteristics
  • Cultural Characteristics
  • Detection of Antibodies
  • Skin Tests
  • MDRTB
    c. Vaccines and Drugs
  66. Vibrio
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  67. West Nile Virus
    a. Background
  • Clinical Syndromes
    b. Diagnostic Tests
    c. Vaccines and Drugs
  68. Yersina
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. Instrumentation Review and Market Needs
  • Abbott AxSYM
  • Abbott IMx/IMx Select
  • Anagen AN2000/AuraFlex
  • Siemens Immuno 1
  • Beckman Coulter Access
  • BioChem Pharma/SR1
  • BioMerieux/Vitek Vidas
  • Biotrol System 7000
  • Chiron ACS: Centaur
  • Chiron ACS: 180
  • Siemens ELISA Processor II/III
  • Siemens/Opus/Plus/Magnum
  • Siemens Stratus
  • J&J Diagnostics Vitros ECi
  • J&J Diagnostics/Amersham Amerlite
  • Olympus PK310
  • Roche Elecsys 1010/2010
  • Roche Cobas Core
  • Roche ES 300/  300AL
  • Roche ES 22
  • Roche ES 33
  • Tosoh AIA-1200/  1200DX/NexIA/  600
  • Wallac/Pharmacia Delfia
C. Emerging Diagnostic Technologies
  1. DNA Probes
    a. Technology Overview
    b. Amplification Methods
  • Polymerase Chain Reaction
    • Robotics
    • Temperature Cyclers
    • PCR Variations
  • Immuno-PCR
  • QC-PCR
  • DAP-PCR
  • Ligase Chain Reaction
  • Branched DNA
  • Q-Beta Replicase
  • Nucleic-Acid Sequence-Based
  • Strand Displacement Activation
  • Self-Sustained Sequence Replicase
  2. Monoclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
  • Overview
  • ELISA
  • Dot Immunobinding Assays
  • Capillary Immunoassays
  • Particle-Membrane Capture Immunoassays
  • Enzyme Amplification
    c. Fluorescent Immunoassays
  • Fluorescence Polarization
  • Time-Resolved Pulse Fluorescence
    d. Luminescence
  • Chemiluminescence
  • Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
    4. Differential Light Scattering
    5. Microcomputers and Automation
    6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. MRI
  11. Gel Microdroplets
  12. Other
D. Personal Testing
E. Worldwide Business Environment
F. Worldwide Market Structure
G. Worldwide Market Size and Growth

FRANCE

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
    4. Established Suppliers
    5. Emerging Suppliers
    6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS
  • Abbott
  • Affymetrix
  • Applera
  • Beckman Coulter
  • Becton Dickinson
  • Binding Site
  • Biomerica
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotrol
  • Biosite
  • Biotest
  • Caliper Technologies
  • Cepheid
  • Chemicon
  • Daiichi
  • DiaSorin
  • Diagast
  • Diamedix
  • Digene
  • Eiken
  • Enzo Biochem
  • Fujirebio
  • GenBio
  • Gene-Tec
  • Hemagen
  • Immunetics
  • Innogenetics
  • Inverness
  • J&J
  • Meridian
  • Nanogen
  • Nissui
  • Olympus
  • Provalis
  • Roche
  • Saliva Diagnostic
  • SeraCare
  • Siemens
  • Third Wave Technologies
  • Thermo Fisher
  • Tosho
  • Trinity Biotech
  • Tropix
  • Wampole Labs
  • Zenith
  • Zeus
Appendix: Assumed Currency Exchange Rates

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories Performing Infectious Disease Tests by Country
Worldwide All Market Segments Total Infectious Disease Test Volume Forecast by Country
Worldwide All Market Segments Total Infectious Disease Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market
Potential For Personal Testing
France Summary Table
All Infectious Diseases
Test Volume and Diagnostics Sales Forecast by Market Segment
France Laboratories Performing Infectious Disease Tests by Market Segment
France Hospital Laboratories Performing Infectious Disease Tests by Bed Size
France Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
France All Market Segments Infectious Disease Test Volume Forecast
France Hospital Laboratories Infectious Disease Test Volume Forecast
France Blood Banks Infectious Disease Test Volume Forecast
France Commercial/Private Laboratories Infectious Disease Test Volume Forecast
France All Market Segments Infectious Disease Diagnostics Market Forecast
France Hospital Laboratories Infectious Disease Diagnostics Market Forecast
France Blood Banks Infectious Disease Diagnostics Market Forecast
France Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
France HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast
Forecast by Market Segment
France HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
France HIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
France Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
France BEA Test Volume and Diagnostics Sales Forecast by Market Segment
France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
France Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
France Candida Test Volume and Diagnostics Sales Forecast by Market Segment
France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
France Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
France CMV Test Volume and Diagnostics Sales Forecast by Market Segment
France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
France Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France EBV Test Volume and Diagnostics Sales Forecast by Market Segment
France Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
France Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
France HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
France Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
France Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
France Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
France Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
France Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
France HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
France HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
France Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
France Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
France Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
France Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
France Measles Test Volume and Diagnostics Sales Forecast by Market Segment
France Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
France Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
France Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
France Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
France Polioma Viruses Test Volume and Diagnostics Sales Forecast by Market Segment
France Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
France Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
France RSV Test Volume and Diagnostics Sales Forecast by Market Segment
France Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment
France Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
France Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
France Scleroderma Test Volume and Diagnostics Sales Forecast by Market Segment
France Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
France Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
France Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
France Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
France Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
France Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
France Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
France AIDS Testing Market Diagnostics Sales by Major Supplier
France Adenovirus Testing Market Diagnostics Sales by Major Supplier
France Campylobacter Testing Market Diagnostics Sales by Major Supplier
France Candida Testing Market Diagnostics Sales by Major Supplier
France Chlamydia Testing Market Diagnostics Sales by Major Supplier
France CMV Testing Market Diagnostics Sales by Major Supplier
France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France Hepatitis Testing Market Diagnostics Sales by Major Supplier
France Hepatitis C Testing Market Diagnostics Sales by Major Supplier
France Herpes Testing Market Diagnostics Sales by Major Supplier
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
France Meningitis Testing Market Diagnostics Sales by Major Supplier
France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
France Mumps Testing Market Diagnostics Sales by Major Supplier
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
France RSV Testing Market Diagnostics Sales by Major Supplier
France Rheumatoid Arthritis Testing Market Diagnostics Sales by Major Supplier
France Rotavirus Testing Market Diagnostics Sales by Major Supplier
France Rubella Testing Market Diagnostics Sales by Major Supplier
France Septicemia Testing Market Diagnostics Sales by Major Supplier
France Shigella Testing Market Diagnostics Sales by Major Supplier
France Streptococci Testing Market Diagnostics Sales by Major Supplier
France Syphilis Testing Market Diagnostics Sales by Major Supplier
France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
France Trichomonas Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
France Infectious Disease Diagnostic Testing Instrumentation
Major Systems Estimated Placements and Installed Base
Skip to top


Ask Your Question

The 2012 French Infectious Disease Testing Market
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: